Endeavor BioMedicines is a private drug discovery company. It has raised $133 million across 2 recorded rounds; the latest was a $133 million Series C in Apr 2024.
PMV mark · valuation
—
Oct 2026
Priced at
—
Total raised
$132.5M
Last round
Later Stage VC (Series C)
Apr 2024
Team — not yet on record
No current team members for Endeavor BioMedicines are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Endeavor BioMedicines with a free account
·Watch Endeavor BioMedicines: the Monday email on marks, rounds and moves
